US$ 27.85
eli lilly tirzepatide patent expiry Is India about to make Ozempic-like weight-loss drugs a whole lot cheaper? Patent Cliff Impact: Eli Lilly's
Description
Full article: @Medscape #GLP1 #Protein #ObesityMedicine #WeightLoss

A needle-free option, 100% online.

A US-based study in people with #T2DM found that GLP-1 agonists not only do NOT increase the risk of pancreatitisbut are actually associated with a lower lifetime risk compared to non-users

Health Canada has approved the first generic version of brand-name Ozempic.
)